Drug Research
Universal Coronavirus Monoclonal Therapy For COVID-19 Strain
Since 2019, the SARS-CoV-2 that produces COVID-19 has tragically highlighted the fragility of humanity to new coronaviruses by killing 6.3 million people globally.
In order to combat SARS-CoV-2 and all of its potentially dangerous variations, namely Beta, Gamma, Delta, Epsilon,...
Drug Research
FDA Examines 2 Other Cancer Approvals Without Revocation
The oncology division of the FDA has recently tightened regulations for expedited approvals and emphasised the significance of patient survival data. Several businesses promptly followed suit and withdrew questionable indicators when the agency applied more pressure. However, some businesses...
Drug Research
COVID-19 Reinfections Are Augmented By BA.5, But Not Usually
It's not your imagination: As infections from the fast mutating BA.5 coronavirus subvariant rise throughout the United States, more people are becoming infected with COVID-19 for the second or third time. However, on aggregate, these reinfections do not appear...
Drug Research
FDA Approves Liquid Epilepsy Drug From Azurity After Denial
On the second attempt, Azurity Pharmaceuticals was able to secure an FDA nod for its zonisamide oral suspension, making it the first firm to do so in the United States. In February 2021, Massachusetts-based Azurity acquired the rights to the...
Drug Research
To Cure Obesity And Hunger, NICE Suggests Imcivree By Rhythm
Imcivree, also known as setmelanotide, has been recommended by the National Institute for Health and Care Excellence (NICE) in its advice for managing obesity and hunger brought on by pro-opiomelanocortin (POMC) inadequacy, according to Rhythm Pharmaceuticals. Patients with a...
Drug Research
Brazil, India, SA Scientists Seek Speedier Antibiotic Nod
According to a paper examining the present environment for antimicrobial development in Brazil, India, and South Africa, lowering regulatory barriers to hasten the clearance of novel antibiotics will aid in the development and accessibility of those drugs.
Given that antibiotics...
News
India Gives 2bn Doses of COVID With A 4-Month Rise In Cases
As daily infections reached a four-month high, the Indian government's COVID-19 vaccinations touched 2 billion on July 17th. Booster doses are currently being administered to all people. Prime Minister Narendra Modi praised the vaccination milestone and celebrated the world's...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read